NASDAQ:JAGX Jaguar Health (JAGX) Stock Price, News & Analysis $1.28 -0.07 (-5.19%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.25▼$1.3950-Day Range$1.28▼$10.1252-Week Range$1.25▼$39.60Volume927,290 shsAverage Volume952,390 shsMarket Capitalization$6.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Get Jaguar Health alerts: Email Address Jaguar Health MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy6.83% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.17Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.69) to ($2.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.36 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Jaguar Health.Read more about Jaguar Health's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted6.83% of the float of Jaguar Health has been sold short.Short Interest Ratio / Days to CoverJaguar Health has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Jaguar Health has recently decreased by 8.79%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldJaguar Health does not currently pay a dividend.Dividend GrowthJaguar Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JAGX. Previous Next 2.3 News and Social Media Coverage News SentimentJaguar Health has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Jaguar Health this week, compared to 2 articles on an average week.Search Interest14 people have searched for JAGX on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Jaguar Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Jaguar Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.01% of the stock of Jaguar Health is held by insiders.Percentage Held by InstitutionsOnly 12.04% of the stock of Jaguar Health is held by institutions.Read more about Jaguar Health's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Jaguar Health are expected to decrease in the coming year, from ($0.69) to ($2.51) per share.Price to Book Value per Share RatioJaguar Health has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Jaguar Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About Jaguar Health Stock (NASDAQ:JAGX)Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company's products include Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing NP-300, a second-generation antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.Read More JAGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JAGX Stock News HeadlinesJuly 23, 2024 | finance.yahoo.comJaguar Health shares slump following Phase III Mytesi failureJuly 23, 2024 | msn.comJaguar Health’s stock slammed after drug that aims to reduce gastro issues in cancer patients fails to meet trial goalsJuly 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…July 23, 2024 | nasdaq.comSector Update: Health Care Stocks Advance in Afternoon TradingJuly 23, 2024 | investorplace.comWhy Is Jaguar Health (JAGX) Stock Down 55% Today?July 23, 2024 | investorplace.comWhy Is Jaguar Health (JAGX) Stock Down 55% Today?July 23, 2024 | msn.comCuteness Overload: This Sweet Jaguar Loves Belly RubsJuly 20, 2024 | finance.yahoo.com1JA.F,0P0001DIFR,0 (1JA.F)July 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…July 19, 2024 | americanbankingnews.comJaguar Health (NASDAQ:JAGX) Lifted to "Hold" at StockNews.comMay 29, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for SchizophreniaMay 29, 2024 | finance.yahoo.comJaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for SchizophreniaMay 28, 2024 | finanznachrichten.deJaguar Health, Inc.: Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional DiarrheaMay 28, 2024 | finance.yahoo.comInvestigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional DiarrheaMay 23, 2024 | finance.yahoo.comJaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis ProductMay 15, 2024 | finance.yahoo.comJaguar Health Inc (JAGX) Q1 2024 Earnings Call Transcript Highlights: Strategic Expansions and ...May 14, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports First Quarter 2024 Financial ResultsMay 14, 2024 | msn.comJAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q1 2024See More Headlines Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/27/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:JAGX CUSIPN/A CIK1585608 Webwww.jaguaranimalhealth.com Phone(415) 371-8300FaxN/AEmployees50Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,300,000.00 Net Margins-377.95% Pretax Margin-383.35% Return on Equity-642.15% Return on Assets-75.53% Debt Debt-to-Equity Ratio1.84 Current Ratio1.89 Quick Ratio1.39 Sales & Book Value Annual Sales$9.76 million Price / Sales0.64 Cash FlowN/A Price / Cash FlowN/A Book Value$4.02 per share Price / Book0.32Miscellaneous Outstanding Shares4,900,000Free Float4,905,000Market Cap$6.27 million OptionableNo Data Beta0.86 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMs. Lisa A. Conte (Age 65)Founder, CEO, President & Director Comp: $610.66kDr. Pravin R. Chaturvedi Ph.D. (Age 61)Chief Scientific Officer & Chair of Scientific Advisory Board Comp: $517.91kDr. Steven R. King Ph.D. (Age 66)Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary Comp: $406.4kMs. Carol R. Lizak M.B.A. (Age 60)Chief Financial Officer Mr. Peter HodgeSenior Director of Investor Relations, Business Development & Special EventsDr. Karen J. Brunke Ph.D. (Age 71)Executive VP of Corporate & Business Development Mr. Ian H. Wendt M.B.A. (Age 56)Chief Commercial Officer Comp: $441.31kDr. Massimo Radaelli M.B.A. (Age 66)Ph.D., President of Jaguar International Ms. Catherine Miller CollisSenior Vice President of Growth StrategyMore ExecutivesKey CompetitorsLipocineNASDAQ:LPCNAkari TherapeuticsNASDAQ:AKTXEquilliumNASDAQ:EQDaré BioscienceNASDAQ:DAREVYNE TherapeuticsNASDAQ:VYNEView All Competitors JAGX Stock Analysis - Frequently Asked Questions How have JAGX shares performed this year? Jaguar Health's stock was trading at $9.0840 on January 1st, 2024. Since then, JAGX shares have decreased by 85.9% and is now trading at $1.28. View the best growth stocks for 2024 here. How were Jaguar Health's earnings last quarter? Jaguar Health, Inc. (NASDAQ:JAGX) issued its quarterly earnings results on Tuesday, May, 14th. The biotechnology company reported ($3.60) EPS for the quarter. The biotechnology company had revenue of $2.35 million for the quarter. Jaguar Health had a negative net margin of 377.95% and a negative trailing twelve-month return on equity of 642.15%. When did Jaguar Health's stock split? Jaguar Health shares reverse split before market open on Thursday, May 23rd 2024. The 1-60 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Jaguar Health IPO? Jaguar Health (JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. How do I buy shares of Jaguar Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Jaguar Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX) and Tonix Pharmaceuticals (TNXP). This page (NASDAQ:JAGX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
